1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "79778-41-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-119443

    Others Cancer
    Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget’s disease of bone (PDB). Neridronate is effective also in other skeletal diseases such as osteoporosis, algodystrophy, hypercalcemia of malignancy, and bone metastases.